Correlation Between Aerovate Therapeutics and Shell PLC
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Shell PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Shell PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Shell PLC, you can compare the effects of market volatilities on Aerovate Therapeutics and Shell PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Shell PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Shell PLC.
Diversification Opportunities for Aerovate Therapeutics and Shell PLC
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aerovate and Shell is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Shell PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shell PLC and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Shell PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shell PLC has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Shell PLC go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Shell PLC
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Shell PLC. In addition to that, Aerovate Therapeutics is 2.6 times more volatile than Shell PLC. It trades about 0.0 of its total potential returns per unit of risk. Shell PLC is currently generating about 0.04 per unit of volatility. If you would invest 2,529 in Shell PLC on December 4, 2024 and sell it today you would earn a total of 811.00 from holding Shell PLC or generate 32.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Aerovate Therapeutics vs. Shell PLC
Performance |
Timeline |
Aerovate Therapeutics |
Shell PLC |
Aerovate Therapeutics and Shell PLC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Shell PLC
The main advantage of trading using opposite Aerovate Therapeutics and Shell PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Shell PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shell PLC will offset losses from the drop in Shell PLC's long position.Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Shell PLC vs. Eni SpA | Shell PLC vs. MOL PLC ADR | Shell PLC vs. PetroChina Co Ltd | Shell PLC vs. Equinor ASA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |